Providence Capital Advisors’s Eli Lilly LLY Stock Holding History

Providence Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$554K	Hold	602	–	–	0.09%	111
2025 Q4	$647K	Hold	602	–	–	0.11%	107
2025 Q3	$459K	Sell	602 -17	-3%	-$12.7K	0.08%	110
2025 Q2	$483K	Buy	619 +117	+23%	+$90.9K	0.09%	113
2025 Q1	$415K	Sell	502 -5	-1%	-$4.16K	0.09%	106
2024 Q4	$391K	Buy	507 +17	+3%	+$14.1K	0.08%	104
2024 Q3	$434K	Hold	490	–	–	0.09%	102
2024 Q2	$444K	Buy	490 +7	+1%	+$5.6K	0.1%	99
2024 Q1	$376K	Hold	483	–	–	0.08%	100
2023 Q4	$282K	Sell	483 -5	-1%	-$2.92K	0.07%	105
2023 Q3	$262K	Buy	488 +5	+1%	+$2.58K	0.07%	109
2023 Q2	$227K	Hold	483	–	–	0.06%	109
2023 Q1	$166K	Hold	483	–	–	0.04%	107
2022 Q4	$177K	Buy	+483	New	+$171K	0.05%	111
2022 Q2	–	Sell	-10	Closed	-$3K	–	386
2022 Q1	$3K	Buy	+10	New	+$2.57K	﹤0.01%	310

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Providence Capital Advisors's LLY Position: Q1 2026 in Review

Providence Capital Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 602 shares worth $554K. The position accounts for 0.09% of the portfolio, ranked #111.

Providence Capital Advisors first reported a position in LLY in Q1 2022 and has held it in 15 quarters since. The position peaked at $647K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Providence Capital Advisors held 602 shares of Eli Lilly worth $554K as of Q1 2026.
Providence Capital Advisors left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 0.09% of Providence Capital Advisors's portfolio in Q1 2026, its #111 holding.
Providence Capital Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 15 quarters since.
Providence Capital Advisors's Eli Lilly position peaked at $647K in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Providence Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.